The history of the erectile dysfunction drug presents a complex picture for shareholders. While the initial launch generated substantial gains, the end of its exclusive rights opened the door to cheaper alternatives, https://jayjdnk138316.tusblogos.com/42484131/sildenafil-and-pharma-a-volatile-bet